Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Gastrointest Endosc. 2018 Jan 9;87(6):1474–1480. doi: 10.1016/j.gie.2017.12.032

Table 4.

Patient follow-up after EUS-FNB.

Characteristics Newly Diagnosed PDA Patients (n = 37)
Median follow-up (weeks) 22 (1 – 103)
Chemotherapy post EUS-FNB (n, %) 21 (57%)
Surgical resection following EUS-FNB (n, %)
   Resected without neoadjuvant treatment
   Resected after neoadjuvant treatment
   Not resected, locally advanced or metastatic

 4 (11%)
 3 (8%)
 30 (81%)
Deceased (n, %) 10 (27%)